Carregant...
Impact of the gut microbiome on immune checkpoint inhibitor efficacy—a systematic review
BACKGROUND: Immune checkpoint inhibitors (icis) are increasingly being used in clinical practice, improving outcomes for cancer patients. Preclinical models showed significant interaction between the gut microbiome (gm) and response to icis. However, that interaction remains unclear in clinical prac...
Guardat en:
| Publicat a: | Curr Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Multimed Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6927774/ https://ncbi.nlm.nih.gov/pubmed/31896938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.5177 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|